SYRE icon

Spyre Therapeutics
SYRE

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$57
155% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Deutsche Bank
Deutsche Bank
David Hoang
100% 1-yr SYRE win rate
26 Sep ‘25 20 days ago
BTIG
BTIG
Julian Harrison
100% 1-yr SYRE win rate
16 Sep ‘25 1 month ago